BDI MONTHLY UPDATES

What's New in January 2025

Happy Holidays and a Happy New Year from your friends here at the Behavioral Diabetes Institute.

A round-up of 2024 BDI research acheivements

During 2024, BDI staff authored or co-authored 24 scientific publications (which includes the 3 new ones highlighted above) and 8 published abstracts at major scientific meetings. You can see the full list right HERE. Our work has covered a wide range, including studies on diabetes distress, the value of continuous glucose monitoring (CGM) for people with diabetes, the impact of diabetes medications on quality of life, the benefits of diabetes technology for people with type 1 and type 2 diabetes, diabetes
stigma, and more.

New Scientific Publications

BDI staff served as co-authors on three new publications this month:

  • How Might We Tell if Advances in Diabetes Care and Technology are Helping People to Feel Less Constrained? Introducing the Diabetes Constraints Scale.
  • Understanding the different stages of type 1 diabetes and their management: a plain language summary.
  • Towards standardization of person-reported outcomes (PROs) in pediatric diabetes research: A consensus report.

JOIN US FOR A LOCAL EVENT

Monthly Events

March 19-22International Conference
18th International Conference for ATTD (Advanced Technologies and Treatments for Diabetes) in Amsterdam, Dr. Polonsky (BDI President) has three presentations.
March 19Type 2 Presentation
On March 19, Dr. Polonski will present CGM is Wonderful, But… at the Roche-sponsored symposium, “Translating the Power of Prediction into Diabetes Management”, and Insulin Therapy Experience: Considering the Needs of People Living with Diabetes (with Professor Cukierman-Yaffe) at the Sanofi-sponsored symposium, Confidence and Simplicity in Diabetes Management”. https://attd.kenes.com/
March 20Type 2 Presentation
On March 20, Dr. Polonski will present Improved Patient- and Physician-Reported Outcomes with IGlarLixi When Switching From Premixed Insulin in People with Type 2 Diabetes: The Soli-Switch Study. https://cslide.ctimeetingtech.com/attd25/attendee/confcal/session/calendar/2025-03-20
March 12Case Consultation Meeting
March 12: BDI hosts the San Diego-wide, monthly case consultation meeting (for mental health professionals working in the field of diabetes). Contact us at info@behavioraldiabetes.org if you are in the greater San Diego area and would like further information about this program.
March 19-22International Conference
18th International Conference for ATTD (Advanced Technologies and Treatments for Diabetes) in Amsterdam, Dr. Polonsky (BDI President) has three presentations.
March 19Type 2 Presentation
On March 19, Dr. Polonski will present CGM is Wonderful, But… at the Roche-sponsored symposium, “Translating the Power of Prediction into Diabetes Management”, and Insulin Therapy Experience: Considering the Needs of People Living with Diabetes (with Professor Cukierman-Yaffe) at the Sanofi-sponsored symposium, Confidence and Simplicity in Diabetes Management”. https://attd.kenes.com/
March 20Type 2 Presentation
On March 20, Dr. Polonski will present Improved Patient- and Physician-Reported Outcomes with IGlarLixi When Switching From Premixed Insulin in People with Type 2 Diabetes: The Soli-Switch Study. https://cslide.ctimeetingtech.com/attd25/attendee/confcal/session/calendar/2025-03-20
March 12Case Consultation Meeting
March 12: BDI hosts the San Diego-wide, monthly case consultation meeting (for mental health professionals working in the field of diabetes). Contact us at info@behavioraldiabetes.org if you are in the greater San Diego area and would like further information about this program.
March 19-22International Conference
18th International Conference for ATTD (Advanced Technologies and Treatments for Diabetes) in Amsterdam, Dr. Polonsky (BDI President) has three presentations.
March 19Type 2 Presentation
On March 19, Dr. Polonski will present CGM is Wonderful, But… at the Roche-sponsored symposium, “Translating the Power of Prediction into Diabetes Management”, and Insulin Therapy Experience: Considering the Needs of People Living with Diabetes (with Professor Cukierman-Yaffe) at the Sanofi-sponsored symposium, Confidence and Simplicity in Diabetes Management”. https://attd.kenes.com/

BEHAVIORAL DIABETES INSTITUTE

Recent Publications

During 2024, BDI staff authored or co-authored 24 scientific publications (which includes the 3 new ones highlighted above) and 8 published abstracts at major scientific meetings. You can see the full list right HERE. Our work has covered a wide range, including studies on diabetes distress, the value of continuous glucose monitoring (CGM) for people with diabetes, the impact of diabetes medications on quality of life, the benefits of diabetes technology for people with type 1 and type 2 diabetes, diabetes stigma, and more.

News

JOIN US FOR A LOCAL EVENT Monthly Events March 12Case Consultation Meeting March 12: BDI hosts the San Diego-wide, monthly

Read More